The effects of combination therapy with dutasteride plus tamsulosin on clinical outcomes in men with symptomatic BPH: 4-year post hoc analysis of European men in the CombAT study

被引:7
|
作者
Haillot, O. [1 ]
Fraga, A. [2 ]
Maciukiewicz, P. [3 ]
Pushkar, D. [4 ]
Tammela, T. [5 ]
Hoefner, K. [6 ]
Chantada, V. [7 ]
Gagnier, P. [8 ]
Morrill, B. [9 ]
机构
[1] Univ F Rabelais, CHRU, F-37044 Tours, France
[2] Inst Portugues Oncol Francisco Gentil, Oporto, Portugal
[3] WSS L Rydygiera, Krakow, Poland
[4] Moscow State Med Stomatol Univ, Dept Urol, Moscow, Russia
[5] Tampere Univ Hosp, Dept Urol, Tampere, Finland
[6] Evangel Krankenhaus, Urol Klin, Oberhausen, Germany
[7] CHU A Coruna, Jefe Serv Urol, La Coruna, Spain
[8] GlaxoSmithKline Inc, Clin Dev & Med Affairs, Raleigh, NC USA
[9] GlaxoSmithKline Inc, Biostat, Raleigh, NC USA
关键词
BPH; CombAT; dutasteride; tamsulosin; combination therapy; BENIGN-PROSTATIC-HYPERPLASIA; URINARY-TRACT SYMPTOMS; FINASTERIDE; TRIAL; ENLARGEMENT; PROGRESSION; RETENTION; COUNTRIES; ANTIGEN; PLACEBO;
D O I
10.1038/pcan.2011.13
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
CombAT (Combination of Avodart and Tamsulosin) was a randomised, double-blind study in men (n = 4844) aged >= 50 years with a clinical diagnosis of BPH. Patients were randomised to daily tamsulosin 0.4 mg, dutasteride 0.5 mg or both for 4 years. The primary endpoint was time to acute urinary retention (AUR) or BPH-related surgery. Secondary endpoints included BPH clinical progression, symptoms and maximum urinary flow rate. A post hoc analysis of data from the European subgroup was conducted. A total of 2925 men were randomised to treatment in Europe as part of CombAT (tamsulosin, n = 972; dutasteride, n = 970; combination, n = 983). Combination therapy significantly reduced the relative risk of AUR or BPH-related surgery compared with either monotherapy at 4 years, and also significantly reduced the risk of BPH clinical progression. Combination therapy also provided significantly greater symptom improvement than either monotherapy at 4 years. Safety and tolerability of dutasteride plus tamsulosin was consistent with previous experience of this combination and with the monotherapies. These data provide further evidence to support the use of long-term combination therapy (dutasteride plus tamsulosin) in men with moderate-to-severe lower urinary tract symptoms because of BPH and prostatic enlargement. The results in the European subgroup are generally consistent with those in the overall study population. Prostate Cancer and Prostatic Diseases (2011) 14, 302-306; doi:10.1038/pcan.2011.13; published online 19 April 2011
引用
收藏
页码:302 / 306
页数:5
相关论文
共 40 条
  • [1] The effects of combination therapy with dutasteride plus tamsulosin on clinical outcomes in men with symptomatic BPH: 4-year post hoc analysis of European men in the CombAT study
    O Haillot
    A Fraga
    P Maciukiewicz
    D Pushkar
    T Tammela
    K Höfner
    V Chantada
    P Gagnier
    B Morrill
    [J]. Prostate Cancer and Prostatic Diseases, 2011, 14 : 302 - 306
  • [2] The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study
    Roehrborn, Claus G.
    Siami, Paul
    Barkin, Jack
    Damiao, Ronaldo
    Major-Walker, Kim
    Nandy, Indrani
    Morrill, Betsy B.
    Gagnier, R. Paul
    Montorsi, Francesco
    [J]. EUROPEAN UROLOGY, 2010, 57 (01) : 123 - 131
  • [3] The Effects of Combination Therapy With Dutasteride and Tamsulosin on Clinical Outcomes in Men With Symptomatic Benign Prostatic Hyperplasia: 4-Year Results From the CombAT Study Editorial Comment
    Kaplan, Steven A.
    [J]. JOURNAL OF UROLOGY, 2011, 185 (04): : 1384 - +
  • [4] EFFECTS OF COMBINATION THERAPY WITH DUTASTERIDE AND TAMSULOSIN ON CLINICAL OUTCOMES IN MEN WITH SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA FOUR YEAR RESULTS FROM THE COMBAT STUDY
    Roehrborn, C. G.
    Barkin, J.
    Siami, P.
    Tubaro, A.
    Damiao, R.
    Gagnier, R. P.
    Castro, R.
    Morrill, B.
    Nandy, I.
    Montorsi, F.
    [J]. JOURNAL OF MENS HEALTH, 2009, 6 (03) : 268 - 268
  • [5] The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study (vol 57, pg 123, 2010)
    Roehrborn, Claus G.
    Siami, Paul
    Barkin, Jack
    Damiao, Ronaldo
    Major-Walker, Kim
    Nandy, Indrani
    Morrill, Betsy B.
    Gagnier, R. Paul
    Montorsi, Francesco
    [J]. EUROPEAN UROLOGY, 2010, 58 (05) : 801 - 801
  • [6] THE EFFECTS OF DUTASTERIDE TAMSULOSIN AND THE COMBINATION ON STORAGE AND VOIDING SYMPTOMS IN MEN WITH MODERATE TO SEVERE BPH 4 YEAR RESULTS FROM THE COMBAT STUDY
    Emberton, M.
    Roehrborn, C.
    Penit, J. Garcia
    Borre, M.
    Roeleveld, T. A.
    Alimi, J. C.
    Gagnier, P.
    Wilson, T. H.
    [J]. JOURNAL OF MENS HEALTH, 2010, 7 (03) : 320 - 321
  • [7] COMBINATION THERAPY WITH DUTASTERIDE PLUS TAMSULOSIN REDUCES MEDICAL RESOURCE UTILISATION IN MEN WITH BENIGN PROSTATIC HYPERPLASIA: 4-YEAR DATA FROM THE COMBAT STUDY
    Montlleo Gonzalez, M.
    Geiges, G.
    Cicalese, V.
    Morrill, B.
    Black, L.
    Castro, R.
    Gagnier, P.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 311 - 311
  • [8] Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulosin (CombAT) trial
    Roehrborn, Claus G.
    Barkin, Jack
    Siami, Paul
    Tubaro, Andrea
    Wilson, Timothy H.
    Morrill, Betsy B.
    Gagnier, R. Paul
    [J]. BJU INTERNATIONAL, 2011, 107 (06) : 946 - 954
  • [9] Change in symptom severity status in 4-year dutasteride studies in men with symptomatic BPH
    Roehrborn, CG
    Dineen, M
    Bock, D
    Siami, P
    [J]. JOURNAL OF UROLOGY, 2004, 171 (04): : 358 - 359
  • [10] THE EFFECTS OF DUTASTERIDE OR TAMSULOSIN ALONE AND IN COMBINATION ON STORAGE AND VOIDING SYMPTOMS IN MEN WITH LOWER URINARY TRACT SYMPTOMS (LUTS) AND BENIGN PROSTATIC HYPERPLASIA (BPH): 4-YEAR DATA FROM THE COMBINATION OF AVODART AND TAMSULOSIN (CombAT) STUDY
    Woo, Henry
    [J]. BJU INTERNATIONAL, 2011, 107 (09) : 1431 - 1431